BDO Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3
Closed -$1K 799
2020
Q1
$1K Sell
3
-3,942
-100% -$742K ﹤0.01% 738
2019
Q4
$754K Sell
3,945
-403
-9% -$72.7K 0.19% 95
2019
Q3
$732K Buy
4,348
+705
+19% +$115K 0.19% 97
2019
Q2
$610K Buy
3,643
+74
+2% +$10.2K 0.17% 100
2019
Q1
$522K Buy
3,569
+406
+13% +$58.9K 0.15% 106
2018
Q4
$423K Sell
3,163
-739
-19% -$121K 0.15% 104
2018
Q3
$743K Buy
3,902
+1,106
+40% +$203K 0.24% 77
2018
Q2
$466K Buy
2,796
+136
+5% +$21.8K 0.16% 96
2018
Q1
$448K Buy
2,660
+889
+50% +$149K 0.17% 89
2017
Q4
$290K Buy
1,771
+125
+8% +$22.4K 0.13% 96
2017
Q3
$337K Sell
1,646
-150
-8% -$34.9K 0.17% 86
2017
Q2
$436K Buy
+1,796
New +$422K 0.19% 87

Other funds holding AGN

BDO Wealth Advisors's AGN Position: Q2 2020 in Review

BDO Wealth Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in AGN in Q2 2017 and held it in 12 quarters. The position peaked at $754K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BDO Wealth Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BDO Wealth Advisors sold 3 Allergan plc shares in Q2 2020, an estimated $1K.
  • BDO Wealth Advisors first reported a position in Allergan plc in Q2 2017 and held it in 12 quarters.
  • BDO Wealth Advisors's Allergan plc position peaked at $754K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BDO Wealth Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.